← Evidence map

ArticleVaccines2024

Preclinical Safety Assessment of the EBS-LASV Vaccine Candidate against Lassa Fever Virus.

Demetrius Matassov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39203984